October 21, 2025 · Form 4 insider transaction
DUGGAN ROBERT W bought 13,980,789 shares of SUMMIT THERAPEUTICS INC at $18.74 per share, a transaction worth $262.00M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025.